Renal anemia and thryoid diseases
Conditions
Interventions
Erythropoietin group:No
Sponsors
Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients signed informed consent file; 2. Patients diagnosed with renal anemia; 3. Aged >= 18 years; 4. Patients received erythropoietin or Roxadustat.
Exclusion criteria
Exclusion criteria: 1. Subjects currently on Levothyroxine or antithyroid medication, amiodarone or lithium; 2. Recent thyroid surgery or radio-iodine therapy (within 12 months); 3. Recent acute coronary syndrome, including myocardial infarction or unstable angina(within 4 weeks); 4. Grade IV NYHA heart failure; 5. Untreated adrenal insufficiency or adrenal disorder; 6. Women who are pregnant or breastfeeding or women of childbearing potential who are not willing to use appropriate contraception; 7. Patients who are participating in or will participate in an investigational interventional study during the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thyroid function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Capacity load;Blood pressure;Biochemistry;Heart rate;C-reactive protein;Blood routine;Grip;ThyPRO (Thyroid-Related Patient-Reported Outcome); | — |
Countries
China
Contacts
Public ContactCheng Yuan
Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University
Outcome results
None listed